Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial - Hansen, Aaron R.; Probst, Stephan; Beauregard, Jean-Mathieu; Viglianti, Benjamin L.; Michalski, Jeff M.; Tagawa, Scott T.; Sartor, Oliver; Tutrone, Ronald F.; Oz, Orhan K.; Courtney, Kevin D.; Delpassand, Ebrahim S.; Nordquist, Luke T.; et al. (Frontiers in Oncology, 2025)